149 related articles for article (PubMed ID: 2838004)
1. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
[TBL] [Abstract][Full Text] [Related]
2. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
Repo H; Leirisalo M; Tiilikainen A; Laitinen O
Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
[TBL] [Abstract][Full Text] [Related]
4. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
[TBL] [Abstract][Full Text] [Related]
5. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
Repo H; Leirisalo-Repo M; Skurnik M; Tiilikainen A
Med Biol; 1984; 62(2):91-4. PubMed ID: 6088912
[TBL] [Abstract][Full Text] [Related]
7. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
Repo H; Leirisalo-Repo M; Koskimies S
Clin Exp Rheumatol; 1988; 6(3):227-31. PubMed ID: 3263238
[TBL] [Abstract][Full Text] [Related]
8. Yersinia arthritis, immune functions and histocompatibility antigens.
Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
[TBL] [Abstract][Full Text] [Related]
9. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous Yersinia arthritis.
Ristola M
APMIS; 1990 Feb; 98(2):125-30. PubMed ID: 2302347
[TBL] [Abstract][Full Text] [Related]
10. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
[TBL] [Abstract][Full Text] [Related]
11. Inflammation in Yersinia arthritis.
Repo H; Meri S; Leirisalo-Repo M
Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
[No Abstract] [Full Text] [Related]
12. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
[TBL] [Abstract][Full Text] [Related]
13. Oxygen radical production and trapping in subjects with previous Yersinia infection.
Ristola M; Metsä-Ketelä T; Leirisalo-Repo M; Repo H
Inflammation; 1992 Jun; 16(3):273-83. PubMed ID: 1323531
[TBL] [Abstract][Full Text] [Related]
14. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
Leirisalo M; Laitinen O; Tiilikainen A
J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil function and HLA-B27.
Repo H; Leirisalo M; Koivuranta P; Osterman T; Kiistala U; Gahmberg CG; Vapaatalo H; Tiilikainen A; Laitinen O
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
[TBL] [Abstract][Full Text] [Related]
16. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
Repo H; Leirisalo-Repo M
Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and HLA-B27.
Meri S; Partanen J; Leirisalo-Repo M; Repo H
Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
[TBL] [Abstract][Full Text] [Related]
18. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
Laitinen O; Leirisalo M; Skylv G
Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
[TBL] [Abstract][Full Text] [Related]
19. Phagocyte function in reactive arthritis.
Leirisalo-Repo M; Repo H
Scand J Rheumatol Suppl; 1988; 76():73-7. PubMed ID: 3075090
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.
Pease CT; Fordham JN; Currey HL
Ann Rheum Dis; 1984 Apr; 43(2):279-84. PubMed ID: 6608924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]